Is Ingram INGM stock showing recovery signs Ingram posts 65 percent EPS beat on strong B2B tech demand Humana Inc HUM Announces Strategic Pharmacy Partnership With Mark Cuban Cost Plus Drug Company to Drive Prescription Affordability and TopLine Growth FGBI First stock falls 296 after posting 95 Q4 2025 EPS miss against analyst consensus estimates